XML 76 R62.htm IDEA: XBRL DOCUMENT
v3.20.4

Fair value of financial instruments and investments - Fair Value Liabilities Measured (Details) $ in Thousands | Dec. 31, 2020 USD ($) | Dec. 31, 2019 USD ($) $ / shares | Dec. 31, 2018 USD ($)
--- | --- | --- | ---
SARs |  |  |
Fair Value Valuation Inputs |  |  |
Fair value | $ 0 |  |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Option Volatility |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input |  | 0.2893 |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Risk Free Interest Rate |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input |  | 0.0019 |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Strike Price | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input | $ / shares |  | 6.76 |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Strike Price | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input | $ / shares |  | 30.86 |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Share Price |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input | $ / shares |  | 48.03 |
SARs | Valuation Technique, Option Pricing Model | Measurement Input, Expected Term |  |  |
Fair Value Valuation Inputs |  |  |
SARs measurement input | $ / shares |  | 0.01 |
Level 3 |  |  |
Fair Value Valuation Inputs |  |  |
Fair value | 101,200 |  |
Level 3 | SARs |  |  |
Fair Value Valuation Inputs |  |  |
Fair value | $ 0 | $ 3,186 | $ 3,814
Development and Regulatory Milestone | Level 3 | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Probability of Success | Weighted Average |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.42 |  |
Development and Regulatory Milestone | Level 3 | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Weighted Average |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.034 |  |
Net Sales Milestones and Royalties | Level 3 | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Probability of Success | Weighted Average |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.48 |  |
Net Sales Milestones and Royalties | Level 3 | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Measurement Input, Discount Rate | Weighted Average |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.115 |  |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Development and Regulatory Milestone | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Potential milestones | $ 0 | 0 |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Development and Regulatory Milestone | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Potential milestones | $ 381,000 | $ 555,000 |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Probability of Success | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.25 | 0.25 |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Probability of Success | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.94 | 0.94 |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.022 | 0.022 |
Agilis | Development and Regulatory Milestone | Contingent Consideration Payable | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.045 | 0.047 |
Agilis | Development and Regulatory Milestone | Level 3 | Contingent Consideration Payable |  |  |
Fair Value Valuation Inputs |  |  |
Fair value | $ 139,200 | $ 290,500 | 257,040
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Sales Milestones | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Potential milestones | 0 | 0 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Sales Milestones | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Potential milestones | $ 150,000 | $ 150,000 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Probability of Success | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.25 | 0.25 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Probability of Success | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.94 | 0.89 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Percentage of Sales for Royalties | Minimum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.02 | 0.02 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Percentage of Sales for Royalties | Maximum |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.06 | 0.06 |
Agilis | Net Sales Milestones and Royalties | Contingent Consideration Payable | Valuation Technique, Option Pricing Model | Measurement Input, Discount Rate |  |  |
Fair Value Valuation Inputs |  |  |
Rights Exchange Settlement measurement | 0.115 | 0.145 |
Agilis | Net Sales Milestones and Royalties | Level 3 | Contingent Consideration Payable |  |  |
Fair Value Valuation Inputs |  |  |
Fair value | $ 101,200 | $ 65,800 | $ 53,200

X
- Definition Value of input used to measure Rights Exchange Settlement. + References No definition available. + Details
Name: | ptct_RightsExchangeSettlementMeasurementInput
Namespace Prefix: | ptct_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The potential milestone payments due under the Rights Exchange Settlement. + References No definition available. + Details
Name: | ptct_RightsExchangeSettlementPotentialMilestonesValue
Namespace Prefix: | ptct_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of input used to measure stock appreciation rights (SARs) + References No definition available. + Details
Name: | ptct_StockAppreciationRightsMeasurementInput
Namespace Prefix: | ptct_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=ptct_MeasurementInputStrikePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=ptct_LiabilityDevelopmentandRegulatoryMilestoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_CommitmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=ptct_ProbabilityofSuccessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=ptct_LiabilityNetSalesMilestonesandRoyaltiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ptct_AgilisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=ptct_DevelopmentandRegulatoryMilestoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=ptct_SalesMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=ptct_PercentageofSalesforRoyaltiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |